{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:50:00Z","timestamp":1764654600494,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002966","name":"Sivas Cumhuriyet University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bladder cancer is a type of urologic malignancy that exhibits significant morbidity, mortality, and treatment costs. Inhibition of heat shock protein 90 (HSP90) activity has been a promising pharmacological strategy for blocking of bladder cancer pathogenesis. BIIB021 is a next-generation HSP90 inhibitor which interrupts ATP hydrolysis process of HSP90 and inhibits the stabilization and correct folding of client proteins. In current study, we aimed to investigate the molecular mechanism of the anticancer activity of BIIB021 in human bladder cancer T24 cells. Our results revealed that nanomolar concentration of BIIB021 decreased viability of T24 cell. BIIB021 downregulated HSP90 expression in T24 cells and inhibited the refolding activity of luciferase in the presence of T24 cell lysate. PCR array data indicated a significant alteration in transcript levels of cancer-related genes involved in metastases, apoptotic cell death, cell cycle, cellular senescence, DNA damage and repair mechanisms, epithelial-to-mesenchymal transition, hypoxia, telomeres and telomerase, and cancer metabolism pathways in T24 cells. All findings hypothesize that BIIB021 could exhibit as effective HSP90 inhibitor in the future for treatment of bladder cancer patients.<\/jats:p>","DOI":"10.1007\/s00210-024-02950-x","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T08:02:23Z","timestamp":1705651343000},"page":"5167-5177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor BIIB021 in human bladder cancer cell line"],"prefix":"10.1007","volume":"397","author":[{"given":"Aydemir","family":"Asdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykut","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"issue":"3","key":"2950_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/cells9030663","volume":"9","author":"R Abbas","year":"2020","unstructured":"Abbas R, Larisch S (2020) Targeting XIAP for promoting cancer cell death-the story of ARTS and SMAC. Cells 9(3):663","journal-title":"Cells"},{"issue":"1","key":"2950_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/carcin\/bgp268","volume":"31","author":"SE Artandi","year":"2010","unstructured":"Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31(1):9\u201318","journal-title":"Carcinogenesis"},{"key":"2950_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241","journal-title":"Eur Urol"},{"issue":"22","key":"2950_CR4","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC (2014) The MAPK pathway across different malignancies: a new perspective. Cancer 120(22):3446\u20133456","journal-title":"Cancer"},{"issue":"5","key":"2950_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells9051261","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Dozmorov M, Oh Y (2020) IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells 9(5):1261","journal-title":"Cells"},{"issue":"3","key":"2950_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/138161206775201910","volume":"12","author":"AR Cardones","year":"2006","unstructured":"Cardones AR, Banez LL (2006) VEGF inhibitors in cancer therapy. Curr Pharm Des 12(3):387\u2013394","journal-title":"Curr Pharm Des"},{"issue":"4","key":"2950_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1021\/pr301055y","volume":"12","author":"Y Che","year":"2013","unstructured":"Che Y, Best OG, Zhong L, Kaufman KL, Mactier S, Raftery M, Graves LM, Mulligan SP, Christopherson RI (2013) Hsp90 Inhibitor SNX-7081 dysregulates proteins involved with DNA repair and replication and the cell cycle in human chronic lymphocytic leukemia (CLL) cells. J Proteome Res 12(4):1710\u20131722","journal-title":"J Proteome Res"},{"issue":"11","key":"2950_CR8","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.18632\/oncotarget.3502","volume":"6","author":"M Chehab","year":"2015","unstructured":"Chehab M, Caza T, Skotnicki K, Landas S, Bratslavsky G, Mollapour M, Bourboulia D (2015) Targeting Hsp90 in urothelial carcinoma. Oncotarget 6(11):8454\u20138473","journal-title":"Oncotarget"},{"key":"2950_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112063","volume":"189","author":"TEMM Costa","year":"2020","unstructured":"Costa TEMM, Raghavendra NM, Penido C (2020) Natural heat shock protein 90 inhibitors in cancer and inflammation. Eur J Med Chem 189:112063","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2950_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/annonc\/mds275","volume":"24","author":"MA Dickson","year":"2013","unstructured":"Dickson MA, Okuno SH, Keohan ML, Maki RG, D\u2019Adamo DR, Akhurst TJ, Antonescu CR, Schwartz GK (2013) Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors. Ann Oncol 24(1):252\u2013257","journal-title":"Ann Oncol"},{"issue":"1","key":"2950_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K, Li X, Dong Z (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20(1):15","journal-title":"Mol Cancer"},{"issue":"2","key":"2950_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/cells9020428","volume":"9","author":"J Dudas","year":"2020","unstructured":"Dudas J, Ladanyi A, Ingruber J, Steinbichler TB, Riechelmann H (2020) Epithelial to mesenchymal transition: a mechanism that fuels cancer radio\/chemoresistance. Cells 9(2):428","journal-title":"Cells"},{"issue":"7","key":"2950_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11912-023-01421-5","volume":"25","author":"G Elayat","year":"2023","unstructured":"Elayat G, Punev I, Selim A (2023) An overview of angiogenesis in bladder cancer. Curr Oncol Rep 25(7):709\u2013728","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"2950_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516","journal-title":"Toxicol Pathol"},{"key":"2950_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-cancerbio-030518-055425","volume":"4","author":"A Francou","year":"2020","unstructured":"Francou A, Anderson KV (2020) The epithelial-to-mesenchymal transition (EMT) in development and cancer. Annu Rev Cancer Biol 4:197\u2013220","journal-title":"Annu Rev Cancer Biol"},{"issue":"1","key":"2950_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2141.2006.06247.x","volume":"135","author":"GV Georgakis","year":"2006","unstructured":"Georgakis GV, Li Y, Younes A (2006) The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 90. Br J Haematol 135(1):68\u201371","journal-title":"Br J Haematol"},{"issue":"20","key":"2950_CR17","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.3390\/ijms20205168","volume":"20","author":"P Gilson","year":"2019","unstructured":"Gilson P, Drouot G, Witz A, Merlin JL, Becuwe P, Harl\u00e9 A (2019) Emerging roles of DDB2 in cancer. Int J Mol Sci 20(20):5168","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2950_CR18","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-12-3510","volume":"19","author":"R Gopalakrishnan","year":"2013","unstructured":"Gopalakrishnan R, Matta H, Chaudhary PM (2013) A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-\u03baB. Clin Cancer Res 19(18):5016\u20135026","journal-title":"Clin Cancer Res"},{"issue":"15","key":"2950_CR19","first-page":"7299","volume":"27","author":"CM G\u00fcven","year":"2023","unstructured":"G\u00fcven CM, \u00d6zg\u00fcr A (2023) BIIB021, an orally available and small-molecule inhibitor of HSP90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa). Eur Rev Med Pharmacol Sci 27(15):7299\u20137308","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2950_CR20","doi-asserted-by":"crossref","unstructured":"Hader C, Marlier A, Cantley (2010) Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2. Oncogene 29(7):1031-1040","DOI":"10.1038\/onc.2009.397"},{"issue":"1","key":"2950_CR21","first-page":"3","volume":"40","author":"W He","year":"2018","unstructured":"He W, Hu H (2018) BIIB021, an Hsp90 inhibitor: a promising therapeutic strategy for blood malignancies (Review). Oncol Rep 40(1):3\u201315","journal-title":"Oncol Rep"},{"issue":"4","key":"2950_CR22","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3892\/ijo.2016.3382","volume":"48","author":"W He","year":"2016","unstructured":"He W, Ye X, Huang X, Lel W, You L, Wang L, Chen X, Qian W (2016) Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells. Int J Oncol 48(4):1710\u20131720","journal-title":"Int J Oncol"},{"issue":"13","key":"2950_CR23","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.18632\/oncotarget.3448","volume":"6","author":"CR Huang","year":"2015","unstructured":"Huang CR, Lee CT, Chang KY, Chang WC, Liu YW, Lee JC, Chen BK (2015) Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin\/integrin \u03b21\/FAK axis. Oncotarget 6(13):11530\u201311546","journal-title":"Oncotarget"},{"issue":"8","key":"2950_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang H, Bhat A, Woodnutt G, Lappe R (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 10(8):575\u2013585","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2950_CR25","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V (2021) Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int J Mol Sci 22(11):5703","journal-title":"Int J Mol Sci"},{"key":"2950_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","volume":"388","author":"GC Jayson","year":"2016","unstructured":"Jayson GC, Kerbel R, Ellis LM, Harris AL (2016) Antiangiogenic therapy in oncology: current status and future directions. Lancet 388:518\u2013229","journal-title":"Lancet"},{"key":"2950_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2010.10.014","volume":"332","author":"G Jego","year":"2013","unstructured":"Jego G, Hazoum\u00e9 A, Seigneuric R, Garrido C (2013) Targeting heat shock proteins in cancer. Cancer Lett 332:275\u2013285","journal-title":"Cancer Lett"},{"key":"2950_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2174\/138920112800784989","volume":"13","author":"V Jendrossek","year":"2012","unstructured":"Jendrossek V (2012) The intrinsic apoptosis pathways as a target in anticancer therapy. Curr Pharm Biotechnol 13:1426\u20131438","journal-title":"Curr Pharm Biotechnol"},{"key":"2950_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12032-023-02107-5","volume":"40","author":"D Karademir","year":"2023","unstructured":"Karademir D, \u00d6zg\u00fcr A (2023) The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells. Med Oncol 40:234","journal-title":"Med Oncol"},{"key":"2950_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tibs.2014.12.002","volume":"40","author":"GE Karag\u00f6z","year":"2015","unstructured":"Karag\u00f6z GE, R\u00fcdiger SG (2015) Hsp90 interaction with clients. Trends Biochem Sci 40:117\u2013125","journal-title":"Trends Biochem Sci"},{"key":"2950_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1471-2407-10-481","volume":"10","author":"PK Karkoulis","year":"2010","unstructured":"Karkoulis PK, Stravopodis DJ, Margaritis LH, Voutsinas GE (2010) 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells. BMC Cancer 10:481","journal-title":"BMC Cancer"},{"key":"2950_CR32","doi-asserted-by":"publisher","unstructured":"Kiss EA, Saharinen P (2019) Anti-angiogenic targets: angiopoietin and angiopoietin receptors. Tumor Angiogenesis.\u00a0https:\/\/doi.org\/10.1007\/978-3-319-33673-2_4","DOI":"10.1007\/978-3-319-33673-2_4"},{"key":"2950_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110448","volume":"38","author":"ES Knudsen","year":"2022","unstructured":"Knudsen ES, Kumarasamy V, Nambiar R, Pearson JD, Vail P, Rosenheck H, Wang J, Eng K, Bremner R, Schramek D, Rubin SM, Welm AL, Witkiewicz AK (2022) CDK\/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities. Cell Rep 38:110448","journal-title":"Cell Rep"},{"key":"2950_CR34","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD (2020) Bladder cancer: a review. JAMA 324:1980\u20131991","journal-title":"JAMA"},{"key":"2950_CR35","doi-asserted-by":"publisher","first-page":"66267","DOI":"10.18632\/oncotarget.11411","volume":"7","author":"HL Li","year":"2016","unstructured":"Li HL, Song J, Yong HM, Hou PF, Chen YS, Song WB, Bai J, Zheng JN (2016) PinX1: structure, regulation and its functions in cancer. Oncotarget 7:66267\u201366275","journal-title":"Oncotarget"},{"key":"2950_CR36","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1021\/acs.jmedchem.9b00940","volume":"63","author":"L Li","year":"2020","unstructured":"Li L, Wang L, You QD, Xu XL (2020) Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions. J Med Chem 63:1798\u20131822","journal-title":"J Med Chem"},{"key":"2950_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41598-017-00143-6","volume":"7","author":"QQ Li","year":"2017","unstructured":"Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK (2017) Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep 7:201","journal-title":"Sci Rep"},{"key":"2950_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/1535-7163.MCT-08-0758","volume":"8","author":"K Lundgren","year":"2009","unstructured":"Lundgren K, Zhang H, Brekken J, Huser N, Powell RE, Timple N, Busch DJ, Neely L, Sensintaffar JL, Yang YC, McKenzie A, Friedman J, Scannevin R, Kamal A, Hong K, Kasibhatla SR, Boehm MF, Burrows FJ (2009) BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90. Mol Cancer Ther 8:921\u2013929","journal-title":"Mol Cancer Ther"},{"key":"2950_CR39","doi-asserted-by":"publisher","first-page":"10883","DOI":"10.3390\/ijms231810883","volume":"23","author":"Z Majercikova","year":"2022","unstructured":"Majercikova Z, Dibdiakova K, Gala M, Horvath D, Murin R, Zoldak G, Hatok J (2022) Different approaches for the profiling of cancer pathway-related genes in glioblastoma CELLS. Int J Mol Sci 23:10883","journal-title":"Int J Mol Sci"},{"key":"2950_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W (2015) HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin b 5:378\u2013389","journal-title":"Acta Pharm Sin b"},{"key":"2950_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/1535-7163.MCT-22-0302","volume":"22","author":"S Mizuno","year":"2023","unstructured":"Mizuno S, Ikegami M, Koyama T, Sunami K, Ogata D, Kage H, Yanagaki M, Ikeuchi H, Ueno T, Tanikawa M, Oda K, Osuga Y, Mano H, Kohsaka S (2023) High-throughput functional evaluation of MAP2K1 variants in cancer. Mol Cancer Ther 22:227\u2013239","journal-title":"Mol Cancer Ther"},{"key":"2950_CR42","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/MOU.0000000000000804","volume":"3","author":"K Mori","year":"2020","unstructured":"Mori K, Mostafaei H, Abufaraj M, Yang L, Egawa S, Shariat SF (2020) Smoking and bladder cancer: review of the recent literature. Curr Opin Urol 3:720\u2013725","journal-title":"Curr Opin Urol"},{"key":"2950_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","volume":"18","author":"L Neckers","year":"2012","unstructured":"Neckers L, Workman P (2012) Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res 18:64\u201376","journal-title":"Clin Cancer Res"},{"key":"2950_CR44","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1158\/1078-0432.CCR-14-1209","volume":"21","author":"AT Ooi","year":"2015","unstructured":"Ooi AT, Gomperts BN (2015) Molecular pathways: targeting cellular energy metabolism in cancer via inhibition of SLC2A1 and LDHA. Clin Cancer Res 21:2440\u20132444","journal-title":"Clin Cancer Res"},{"key":"2950_CR45","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s11033-021-06392-z","volume":"48","author":"A \u00d6zg\u00fcr","year":"2021","unstructured":"\u00d6zg\u00fcr A, Kara A, G\u00f6k\u015fen Tosun N, Tekin \u015e, G\u00f6k\u00e7e \u0130 (2021) Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines. Mol Biol Rep 48:3439\u20133449","journal-title":"Mol Biol Rep"},{"key":"2950_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/1871520615666150821093747","volume":"16","author":"A \u00d6zg\u00fcr","year":"2016","unstructured":"\u00d6zg\u00fcr A, Tutar Y (2016) Heat shock protein 90 inhibition in cancer drug discovery: from chemistry to futural clinical applications. Anticancer Agents Med Chem 16:280\u2013290","journal-title":"Anticancer Agents Med Chem"},{"key":"2950_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/etm.2022.11776","volume":"25","author":"Z Peng","year":"2022","unstructured":"Peng Z, Pang H, Wu H, Peng X, Tan Q, Lin S, Wei B (2022) CCL2 promotes proliferation, migration and angiogenesis through the MAPK\/ERK1\/2\/MMP9, PI3K\/AKT, Wnt\/\u03b2-catenin signaling pathways in HUVECs. Exp Ther Med 25:77","journal-title":"Exp Ther Med"},{"key":"2950_CR48","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3390\/cells11162556","volume":"11","author":"X Ren","year":"2022","unstructured":"Ren X, Li T, Zhang W, Yang X (2022) Targeting Heat-Shock Protein 90 in cancer: an update on combination therapy. Cells 11:2556","journal-title":"Cells"},{"key":"2950_CR49","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1078-0432.CCR-13-1257","volume":"20","author":"MW Saif","year":"2014","unstructured":"Saif MW, Takimoto C, Mita M, Banerji U, Lamanna N, Castro J, O\u2019Brien S, Stogard C, Von Hoff D (2014) A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors. Clin Cancer Res 20:445\u2013455","journal-title":"Clin Cancer Res"},{"key":"2950_CR50","doi-asserted-by":"publisher","first-page":"1609802","DOI":"10.3389\/pore.2021.1609802","volume":"27","author":"A Sebesty\u00e9n","year":"2021","unstructured":"Sebesty\u00e9n A, Kopper L, Dank\u00f3 T, T\u00edm\u00e1r J (2021) Hypoxia signaling in cancer: from basics to clinical practice. Pathol Oncol Res 27:1609802","journal-title":"Pathol Oncol Res"},{"key":"2950_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2183\/pjab.87.167","volume":"87","author":"M Shibuya","year":"2011","unstructured":"Shibuya M (2011) Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia. Proc Jpn Acad Ser B Phys Biol Sci 87:167\u2013178","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2950_CR52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6603487","volume":"96","author":"JL Su","year":"2007","unstructured":"Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML (2007) The role of the VEGF-C\/VEGFR-3 axis in cancer progression. Br J Cancer 96:541\u2013545","journal-title":"Br J Cancer"},{"key":"2950_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/mutage\/gez026","volume":"35","author":"AE Tomkinson","year":"2020","unstructured":"Tomkinson AE, Naila T, Khattri BS (2020) Altered DNA ligase activity in human disease. Mutagenesis 35:51\u201360","journal-title":"Mutagenesis"},{"key":"2950_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D (2021) Advances in bladder cancer biology and therapy. Nat Rev Cancer 21:104\u2013121","journal-title":"Nat Rev Cancer"},{"key":"2950_CR55","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12079-021-00657-9","volume":"16","author":"M Tran","year":"2022","unstructured":"Tran M, Leflein SA, Gonzalez ME, Kleer CG (2022) The matricellular protein CCN6 differentially regulates mitochondrial metabolism in normal epithelium and in metaplastic breast carcinomas. J Cell Commun Signal 16:433\u2013445","journal-title":"J Cell Commun Signal"},{"key":"2950_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hon.3110","volume":"41","author":"F Wang","year":"2023","unstructured":"Wang F, Zhang H, He B, Liu Z, Wu X, Liu Y, Xu X, Gou X, Wang H, Yang Q (2023) Heat shock protein 90 inhibitors induce cell differentiation via the ubiquitin-dependent aurora kinase A degradation in a MPLW515L mouse model of primary myelofibrosis. Hematol Oncol 41:474\u2013486","journal-title":"Hematol Oncol"},{"key":"2950_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-021-01898-7","volume":"40","author":"SH Wang","year":"2021","unstructured":"Wang SH, Chen YL, Hsiao JR, Tsai FY, Jiang SS, Lee AY, Tsai HJ, Chen YW (2021) Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-\u03baB\/IL-6\/ROS signaling. J Exp Clin Cancer Res 40:95","journal-title":"J Exp Clin Cancer Res"},{"key":"2950_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/ijo.2014.2399","volume":"45","author":"X Wang","year":"2014","unstructured":"Wang X, Chen M, Zhou J, Zhang X (2014a) HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol 45:18\u201330","journal-title":"Int J Oncol"},{"key":"2950_CR59","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbrc.2014.09.026","volume":"452","author":"XT Wang","year":"2014","unstructured":"Wang XT, Bao CH, Jia YB, Wang N, Ma W, Liu F, Wang C, Wang JB, Song QX, Cheng YF (2014b) BIIB021, a novel Hsp90 inhibitor, sensitizes esophageal squamous cell carcinoma to radiation. Biochem Biophys Res Commun 452:945\u2013950","journal-title":"Biochem Biophys Res Commun"},{"key":"2950_CR60","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/1055-9965.EPI-19-1507","volume":"29","author":"H Yin","year":"2020","unstructured":"Yin H, Hardikar S, Lindstroem S, Hsu L, Anderson KE, Banbury BL, Berndt SI, Chan AT, Giovanucci EL, Harrison TA, Joshi AD, Nan H, Potter JD, Sakoda LC, Slattery ML, Schoen RE, White E, Peters U, Newcomb PA (2020) Telomere maintenance variants and survival after colorectal cancer: smoking- and sex-specific associations. Cancer Epidemiol Biomarkers Prev 29:1817\u20131824","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2950_CR61","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.4161\/cc.10.24.18616","volume":"10","author":"S Yoshida","year":"2011","unstructured":"Yoshida S, Koga F, Tatokoro M, Kawakami S, Fujii Y, Kumagai J, Neckers L, Kihara K (2011) Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle 10:4291\u20134299","journal-title":"Cell Cycle"},{"key":"2950_CR62","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.2147\/OTT.S136367","volume":"10","author":"G Zhou","year":"2017","unstructured":"Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T (2017) The role of desmosomes in carcinogenesis. Onco Targets Ther 10:4059\u20134063","journal-title":"Onco Targets Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-02950-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T14:32:23Z","timestamp":1718116343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-02950-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-02950-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"assertion":[{"value":"3 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree with the publication of this manuscript in this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}